Pravdina N F, Shobukhov V M, Petrova I G, Tul'kes S G, Galegov G A
Biull Eksp Biol Med. 1985 Jan;99(1):74-6.
The authors studied the pharmacodynamics of remantadin in fetuses, liver, kidneys and spleen of pregnant mice after a single oral administration of 3H-remantadin in a dose of 2.8 mg/kg. Thirty to 60 min after the drug administration the fetuses and tissues showed the maximal amount of the drug penetrating an organ. The greatest amount of remantadin was detected in the liver, the least amount in the kidneys and fetuses. The drug half-life in organs and fetuses did not exceed 2 hours. Twelve hours after the drug administration the kidneys and spleen demonstrated remantadin traces (less than 0.1%), the fetuses showed 0.2% and the liver about 0.7% of the drug. It is concluded that remantadin is marked by good placenta permeability and that it is completely eliminated from the fetus.
作者以2.8毫克/千克的剂量单次口服3H-金刚烷胺后,研究了其在怀孕小鼠胎儿、肝脏、肾脏和脾脏中的药效学。给药后30至60分钟,胎儿和组织中药物穿透器官的量达到最大值。肝脏中检测到的金刚烷胺量最多,肾脏和胎儿中最少。药物在器官和胎儿中的半衰期不超过2小时。给药12小时后,肾脏和脾脏中显示有金刚烷胺痕迹(小于0.1%),胎儿中显示为0.2%,肝脏中约为0.7%。得出的结论是,金刚烷胺具有良好的胎盘通透性,且能从胎儿体内完全消除。